Mirae Asset Global Investments’s Health Catalyst HCAT Stock Holding History

Mirae Asset Global Investments’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-25,818	Closed	-$291K	–	1967
2024 Q1	$291K	Hold	25,818	–	–	﹤0.01%	2120
2023 Q4	$239K	Hold	25,818	–	–	﹤0.01%	2280
2023 Q3	$261K	Hold	25,818	–	–	﹤0.01%	2194
2023 Q2	$323K	Hold	25,818	–	–	﹤0.01%	2150
2023 Q1	$301K	Hold	25,818	–	–	﹤0.01%	2166
2022 Q4	$274K	Buy	25,818 +3,124	+14%	+$30.2K	﹤0.01%	2188
2022 Q3	$220K	Buy	22,694 +7,774	+52%	+$103K	﹤0.01%	2301
2022 Q2	$216K	Buy	+14,920	New	+$254K	﹤0.01%	2123

Other funds holding HCAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Daventry Group New York $133M AUM 32.28% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mirae Asset Global Investments's HCAT Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Health Catalyst (HCAT) in Q2 2024, closing a stake of 25,818 shares — an estimated $291K sold.

Mirae Asset Global Investments first reported a position in HCAT in Q2 2022 and held it in 8 quarters. The position peaked at $323K in Q2 2023. 161 funds tracked by Wall St. Rank hold HCAT as of Q2 2024.

Mirae Asset Global Investments reported no remaining Health Catalyst position as of Q2 2024 after selling out during the quarter.
Mirae Asset Global Investments sold 25,818 Health Catalyst shares in Q2 2024, an estimated $291K.
Mirae Asset Global Investments first reported a position in Health Catalyst in Q2 2022 and held it in 8 quarters.
Mirae Asset Global Investments's Health Catalyst position peaked at $323K in Q2 2023.
161 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.